EMPLOYEE PRIVACY | 2026-11-10
Cannabis Hiring Discrimination Under SB 700 and FEHA: California 2026
California FEHA now bars discrimination based on off-duty cannabis use, metabolite drug tests, and questions about an applicant's past cannabis use.
By Anatolii Trembach, Esq. (California State Bar No. 349304; LL.M., USC Gould School of Law; admitted to the U.S. Court of International Trade), Trembach Law Firm, APC · Published
As of January 1, 2024, California employers can no longer freely penalize most workers for off-duty cannabis use or for a drug test that detects nonpsychoactive metabolites. AB 2188 and SB 700 amended FEHA, Gov. Code 12954, to bar off-duty cannabis discrimination, metabolite-based testing, and quest
California Now Limits Cannabis-Based Hiring Discrimination
As of January 1, 2024, California employers can no longer freely refuse to hire, fire, or penalize most workers simply because they use cannabis off the job or because a drug test detects nonpsychoactive cannabis metabolites. Two statutes work together to create this protection. Assembly Bill 2188 (2022) amended the Fair Employment and Housing Act to bar discrimination based on off-the-job, off-premises cannabis use and on certain cannabis-metabolite test results. Senate Bill 700 (2023) amended the same part of FEHA, Gov. Code § 12954, to make it unlawful, with limited exceptions, for an employer to ask a job applicant about prior cannabis use. Together they mark one of the most significant shifts in California off-duty-conduct and privacy law in a decade.
This guide explains what the new FEHA rules prohibit, what they still allow, which jobs are carved out, how the science of cannabis metabolites drives the statute, and how both applicants and employers should respond. Because cannabis remains federally illegal under the Controlled Substances Act, 21 U.S.C. § 812, the interaction between state protection and federal requirements is where most of the hard questions live.
What the Law Protects
Under Gov. Code § 12954 as amended by AB 2188, it is unlawful for an employer to discriminate against a person in hiring, termination, or any term or condition of employment based on the person's use of cannabis off the job and away from the workplace. The statute also bars an employer from relying on a drug-screening test that detects nonpsychoactive cannabis metabolites in the applicant's or employee's hair, blood, urine, or other bodily fluids. The protection recognizes a basic scientific point: the presence of metabolites does not establish current impairment or on-the-job use.
SB 700 added a hiring-stage protection. It makes it unlawful under § 12954 for an employer to request information from an applicant relating to the applicant's prior use of cannabis. That closes a loophole that would have let employers screen out cannabis users through questionnaires and background checks even though the on-the-job test result could no longer be used against them. Information about prior cannabis use obtained from a criminal-history search that the employer is otherwise permitted to consider is treated under separate rules, but the general bar on asking is now the baseline.
The Science Behind the Metabolite Rule
The statute turns on the difference between psychoactive THC and nonpsychoactive metabolites. After a person uses cannabis, the body metabolizes THC into compounds that can linger in urine, hair, and blood for days or weeks after any impairing effect has worn off. A standard urine test that flags these nonpsychoactive metabolites therefore tells an employer only that the person used cannabis at some point in the recent past, not that the person is impaired at work or used cannabis on the premises. The Legislature concluded that penalizing a worker on that basis is effectively punishing lawful off-duty conduct, which California has long protected in other contexts.
By contrast, a test designed to identify the presence of active, psychoactive THC, or an impairment-based evaluation, remains available to employers. The statute draws the line at the type of test and what it actually measures.
What Employers May Still Do
The new rules are not a license to be high at work. Gov. Code § 12954 expressly preserves the employer's right to maintain a drug-free and impairment-free workplace. An employer may still prohibit the possession, use, or impairment by cannabis on the job or during work hours, and may still discipline or refuse to hire a person who is impaired at work. Employers may also use lawful preemployment and employment drug screens that do not screen for nonpsychoactive cannabis metabolites, including scientifically valid tests that identify active psychoactive THC. In short, the statute protects off-duty use and metabolite-only results, not workplace impairment.
Employers that want enforceable impairment policies should move toward impairment-based testing and documentation of observed on-the-job behavior rather than relying on legacy metabolite panels that can no longer support an adverse action for most roles.
The Exceptions
The protections contain carve-outs. They do not apply to employees in the building and construction trades. They also do not apply to applicants or employees hired for positions that require a federal government background investigation or security clearance. And the statute does not preempt state or federal laws that require applicants or employees to be tested for controlled substances, including laws that condition federal funding, federal licensing, or a federal contract on such testing. For example, certain transportation roles governed by federal testing rules fall outside the state protection to the extent federal law requires the test.
These exceptions matter because they are where many employers will try to fit a position to escape the rule. The carve-outs are specific, and an employer that stretches a non-covered label onto an ordinary job invites a FEHA claim.
How This Fits Into California Off-Duty and Privacy Law
The cannabis amendments build on a long California tradition of protecting lawful off-duty conduct and limiting employer reach into private life. Labor Code § 96(k) and § 98.6 protect certain lawful off-duty activity, and Labor Code § 432.7 restricts the use of certain arrest and marijuana-conviction records in hiring. The FEHA cannabis rules extend that philosophy to one of the most common screening practices in American employment. Workers concerned about broader monitoring and surveillance should also understand the common-law privacy framework; our discussion of employee privacy and intrusion upon seclusion after Hernandez v. Hillsides explains how California courts weigh an employee's reasonable expectation of privacy against employer interests.
Federal Illegality and the Preemption Question
Cannabis remains a Schedule I controlled substance under federal law, 21 U.S.C. § 812, and the state cannot force an employer to violate a binding federal testing mandate. That is why the statute expressly preserves federally required testing. But the mere fact that cannabis is federally illegal does not, by itself, let a private California employer ignore the FEHA protection. Unless a specific federal law requires the test or clearance, a private employer in California must comply with § 12954. Employers that assume federal illegality trumps the state rule across the board are exposed to liability.
What an Applicant or Employee Must Prove
A worker alleging a violation generally must show that the employer is covered by FEHA, that the employer took an adverse action such as rescinding an offer or terminating employment, and that the action was based on off-duty cannabis use, on a drug test that screened for nonpsychoactive metabolites, or on a prohibited request for information about prior cannabis use. As with other FEHA claims, the employee must usually exhaust administrative remedies by obtaining a right-to-sue notice from the Civil Rights Department before filing in court. Causation is proved through the timing of the test result, the employer's stated reason, and whether the position fits any statutory exception.
Remedies Under FEHA
Because the cannabis protections live inside FEHA (Gov. Code § 12940 et seq.), a successful plaintiff can pursue the full range of FEHA remedies, which can include back pay and front pay, reinstatement or instatement to the position, compensatory damages for emotional distress, attorney's fees, and, where the conduct is sufficiently egregious, punitive damages. The availability of fees and emotional-distress damages makes these claims meaningfully different from a bare wage claim and gives employers a strong incentive to update testing practices.
Compliance Steps for Employers
Employers should audit every drug-testing panel and remove nonpsychoactive-metabolite screening for all positions that are not covered by a statutory exception. Application forms, background-check questionnaires, and interview scripts must be scrubbed of questions about prior cannabis use. Managers and recruiters should be trained that a positive legacy test or a disclosed history of off-duty use is not, standing alone, a lawful basis to reject a California applicant. Policies should pivot to impairment: observed behavior, active-THC testing where appropriate, and clear rules against possession and impairment on the job. Keep careful documentation whenever a position is treated as exempt so the exemption can be defended.
How Proposition 64 Set the Stage
The new employment protections did not arrive in a vacuum. California voters legalized adult recreational cannabis use through Proposition 64 in 2016, and personal possession and use by adults is now addressed in the Health and Safety Code, including Health & Safety Code § 11362.1, which decriminalized limited personal possession and use. Legalization created a growing population of workers who use cannabis lawfully off the clock, exactly as they might use alcohol. Yet for years employers could still terminate or refuse to hire those workers based on a positive metabolite test, because legalization of the conduct did not by itself create an employment protection. AB 2188 and SB 700 closed that gap by writing an anti-discrimination rule into FEHA, aligning employment law with the reality that off-duty cannabis use is lawful for adults in California.
Understanding this history matters because it explains the statute's careful line between protecting lawful off-duty use and preserving the employer's right to a safe, impairment-free workplace.
Ross v. RagingWire and the Old Rule
Before these amendments, California law ran the other way. In Ross v. RagingWire Telecommunications, Inc. (2008), the California Supreme Court held that FEHA did not require an employer to accommodate an employee's use of medical marijuana, even when recommended by a physician, in part because cannabis remained illegal under federal law. For more than a decade, Ross meant that even a qualified medical-cannabis patient could be fired for a positive test. The 2022 and 2023 amendments to Gov. Code § 12954 represent a deliberate legislative response to that landscape, shifting the default so that off-duty use and metabolite-only test results can no longer support an adverse action for most positions. Workers and employers relying on older guidance that cites Ross for the proposition that any cannabis use is fair game for termination are now working from outdated law.
Preexisting Off-Duty and Record Protections
California already limited employer reach into lawful off-duty conduct before the cannabis amendments, and those protections still operate alongside the new rules. Labor Code § 96(k) allows the Labor Commissioner to pursue claims for employees disciplined for lawful conduct occurring during nonworking hours away from the employer's premises, and Labor Code § 98.6 prohibits retaliation for exercising certain protected rights. Separately, Labor Code § 432.7 restricts an employer's ability to ask about or rely on certain arrest records and specified marijuana-related convictions in hiring decisions. Read together with the new Gov. Code § 12954 rules, these statutes form an increasingly strong barrier against penalizing workers for lawful private conduct and stale, low-level cannabis records.
Building a Lawful Impairment Policy
Because the statute preserves the employer's right to bar impairment at work, the compliant path forward is an impairment-based policy. A strong policy defines prohibited conduct as possession, use, or being impaired by cannabis on the job or during work hours; trains supervisors to document specific, observable signs of impairment such as behavior, coordination, speech, and performance; and relies on testing methods that identify active psychoactive THC or that otherwise measure current impairment rather than legacy metabolites. Employers should calibrate reasonable-suspicion testing to documented observations, not to a stereotype about a worker's off-duty life. A policy drafted this way lets the employer protect safety while staying inside Gov. Code § 12954.
Safety-Sensitive and Federally Regulated Roles
Safety-sensitive positions require careful handling. Where a position is governed by a federal testing mandate, such as certain U.S. Department of Transportation rules for commercial drivers, the statute does not preempt the federally required test, and the worker is outside the state protection to that extent because cannabis remains a Schedule I substance under 21 U.S.C. § 812. But an employer cannot simply label an ordinary job safety-sensitive to escape the rule. The exemptions for the building and construction trades and for positions requiring a federal background investigation or security clearance are specific, and a role that does not genuinely fit one of them remains protected. Employers should document why a position qualifies for an exemption before relying on it.
Scenarios That Illustrate the Line
Two scenarios show how the rule works. First, an applicant for an office role passes the interview, receives an offer contingent on a drug screen, and tests positive only for nonpsychoactive metabolites from weekend use. Rescinding the offer on that basis violates Gov. Code § 12954. Second, an employee arrives at a worksite visibly impaired, with documented coordination and performance problems, and a supervisor observes the impairment. Disciplining that employee for on-the-job impairment is permitted, because the statute protects off-duty use, not workplace impairment. The difference is whether the adverse action rests on lawful private conduct and a metabolite result, or on genuine impairment at work.
The Hiring-Stage Protection in Detail
SB 700's addition to Gov. Code § 12954 deserves close attention because it operates earlier than the testing rule. It makes it unlawful, with limited exceptions, for an employer to request information from an applicant about the applicant's prior use of cannabis. That reaches not only direct interview questions but also application forms and questionnaires designed to surface cannabis history. The protection recognizes that the right to be free from metabolite-based rejection would be hollow if an employer could simply ask an applicant to self-report past use and reject them on that basis. Employers should audit every document and script used in recruiting to remove inquiries about prior cannabis use, and should train interviewers not to probe the subject. The statute does carve out information about cannabis obtained from a criminal-history search that the employer is otherwise permitted to consider under applicable law, but that narrow allowance does not reopen general questioning about use.
The combined effect of the testing rule and the hiring-stage rule is a two-layer shield: an employer can neither screen out an applicant through a metabolite test nor interrogate the applicant about past use to reach the same result.
Interaction With the Interactive Process and Disability Law
Cannabis questions sometimes overlap with disability accommodation, because some workers use cannabis to manage a medical condition. While the FEHA cannabis amendments protect off-duty use and bar metabolite-based discrimination, a worker with an underlying disability may separately be entitled to the interactive process and reasonable accommodation of that disability under Gov. Code § 12940. Employers should be careful not to treat a positive cannabis test as a reason to skip disability obligations that arise from the underlying medical condition. The two frameworks operate on different axes: one protects lawful off-duty conduct, the other protects qualified individuals with disabilities. An employer that conflates them, or that uses cannabis as a pretext to avoid engaging in the interactive process, risks liability under both.
Recordkeeping and Litigation Proof
In a dispute, documentation drives the outcome. A worker who believes a cannabis-based rejection or termination violated Gov. Code § 12954 should preserve the job offer or application, the drug-test result and the laboratory's description of what it screened for, any interview notes or forms asking about cannabis, and the employer's stated reason for the adverse action. The key factual questions are whether the test screened for nonpsychoactive metabolites, whether the employer asked about prior use, and whether the position genuinely fits a statutory exception such as the building and construction trades or a federally mandated test under 21 U.S.C. § 812. Employers, conversely, should keep records showing that any adverse action rested on documented on-the-job impairment or on a position properly within an exemption, so they can rebut the inference that the decision was based on lawful off-duty use.
What Changed on January 1, 2024
The effective date matters for anyone evaluating a claim. AB 2188 was enacted in 2022 but took effect on January 1, 2024, and SB 700, enacted in 2023, is part of the same effective framework under Gov. Code § 12954. Conduct before that date is generally governed by the older rules, under which an employer could lawfully rely on a metabolite test and, under Ross v. RagingWire, was not required to accommodate cannabis use. Adverse actions on or after January 1, 2024 are measured against the new protections. A worker assessing whether a rejection or termination was unlawful should therefore pin down the date of the adverse action and the nature of the test used, because both are outcome-determinative. Employers, likewise, should recognize that policies drafted before 2024 almost certainly need revision, since legacy metabolite panels and prior-use questionnaires that were once standard are now potential liability under § 12954.
Talk to a California employment lawyer about cannabis and hiring. If a California employer withdrew a job offer, fired you, or rejected your application based on off-duty cannabis use or a metabolite drug test, the attorneys at Trembach Law Firm can assess whether your rights under Gov. Code § 12954 were violated. Call (213) 645-2246 for a confidential consultation. For current developments, see our California employment law news.
Frequently Asked Questions
Can a California employer fire me for using cannabis on the weekend?
Generally no, if your role is not within a statutory exception. Gov. Code § 12954 bars discrimination based on off-the-job, off-premises cannabis use. Employers may still prohibit possession and impairment at work.
Can an employer still drug test me?
Yes, but it cannot rely on a test that screens for nonpsychoactive cannabis metabolites for covered positions. Employers may use impairment-based testing or tests that detect active psychoactive THC.
Can a job application ask about my past cannabis use?
Generally no. SB 700 amended § 12954 to make it unlawful, with limited exceptions, for an employer to request information about an applicant's prior cannabis use.
Which jobs are not protected?
Employees in the building and construction trades and positions requiring a federal background investigation or security clearance are carved out, and the law does not preempt federally required testing.
What can I recover if my rights were violated?
Because the protection is part of FEHA, remedies can include back pay, reinstatement or instatement, emotional-distress damages, attorney's fees, and in egregious cases punitive damages.
This article is provided for general informational purposes only and is not legal advice. Reading it does not create an attorney-client relationship. Every case depends on its own facts, and no particular outcome is guaranteed.
Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.
Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301